Skip to content 
Serious Side Effects? (6/10)
To this day, some people — including certain scientists — continue to question whether COVID-19 vaccines may be linked to various health conditions.
A recent large-scale study examined this question further.
This study was conducted by the Global Vaccine Data Network, involving more than 99 million people across eight countries: Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland.
Its findings were published in the scientific journal Vaccine.
Words From the Researchers (8/10)
“Most of the vaccinated individuals were between 20 and 59 years old, and France was the country where the highest number of doses were administered,” the researchers explained. The vaccines examined were produced by Pfizer, Moderna, and AstraZeneca.
These results added to the ongoing debates among healthcare professionals and patients alike.
Guillain-Barré Syndrome and Venous Thrombosis (9/10)
Researchers observed an increase in cases of Guillain-Barré syndrome (GBS) and cerebral venous thrombosis (CVT) following the first dose of the AstraZeneca vaccine.